MMH
TEVA icon

Menora Mivtachim Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Menora Mivtachim Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19B Buy
39,626,383
+310,200
+0.8% +$9.98M 5.65% 3
2025
Q4 		$1.23B Buy
39,316,183
+395,889
+1% +$9.75M 5.77% 5
2025
Q3 		$786M Buy
38,920,294
+427,000
+1% +$7.5M 3.99% 5
2025
Q2 		$645M Buy
38,493,294
+9,303,978
+32% +$150M 3.71% 7
2025
Q1 		$449M Buy
29,189,316
+808,074
+3% +$14.4M 2.91% 8
2024
Q4 		$626M Sell
28,381,242
-456,797
-2% -$8.31M 3.92% 6
2024
Q3 		$520M Hold
28,838,039
– – 3.27% 8
2024
Q2 		$469M Buy
28,838,039
+709,295
+3% +$10.9M 3.18% 8
2024
Q1 		$397M Hold
28,128,744
– – 2.98% 8
2023
Q4 		$294M Hold
28,128,744
– – 2.47% 10
2023
Q3 		$287M Buy
28,128,744
+1,550,184
+6% +$14.4M 2.6% 9
2023
Q2 		$200M Sell
26,578,560
-62,658
-0.2% -$508K 1.85% 19
2023
Q1 		$236M Buy
26,641,218
+3,376,658
+15% +$33.4M 2.44% 10
2022
Q4 		$212M Sell
23,264,560
-43,000
-0.2% -$375K 3.57% 8
2022
Q3 		$188M Sell
23,307,560
-3,050
-0% -$27K 3.55% 7
2022
Q2 		$175M Hold
23,310,610
– – 3.19% 8
2022
Q1 		$219M Buy
23,310,610
+308,328
+1% +$2.57M 3.17% 9
2021
Q4 		$184M Buy
23,002,282
+3,437,762
+18% +$31M 2.51% 14
2021
Q3 		$191M Buy
19,564,520
+3,210,560
+20% +$30.1M 2.78% 12
2021
Q2 		$162M Hold
16,353,960
– – 2.33% 17
2021
Q1 		$189M Buy
16,353,960
+1,189,250
+8% +$13.6M 3.09% 11
2020
Q4 		$146M Buy
15,164,710
+1,824,710
+14% +$17.5M 2.56% 17
2020
Q3 		$120M Sell
13,340,000
-4,585,000
-26% -$48.5M 2.67% 13
2020
Q2 		$221M Buy
17,925,000
+1,370,000
+8% +$15.5M 5.42% 1
2020
Q1 		$149M Buy
16,555,000
+8,150,000
+97% +$83.5M 4.05% 5
2019
Q4 		$82.4M Buy
+8,405,000
New +$75M 1.96% 24
2019
Q2 		– Sell
-1,963,896
Closed -$30.8M – 82
2019
Q1 		$30.8M Sell
1,963,896
-1,694,583
-46% -$29.9M 0.83% 50
2018
Q4 		$56.4M Buy
3,658,479
+3,600,000
+6,156% +$73.8M 1.63% 23
2018
Q3 		$1.26M Hold
58,479
– – 0.03% 86
2018
Q2 		$1.42M Hold
58,479
– – 0.04% 90
2018
Q1 		$999K Sell
58,479
-205,341
-78% -$4.01M 0.03% 85
2017
Q4 		$5M Sell
263,820
-2,500,000
-90% -$37.6M 0.19% 68
2017
Q3 		$48.6M Buy
2,763,820
+2,184,343
+377% +$49.1M 1.97% 18
2017
Q2 		$19.3M Sell
579,477
-41,026
-7% -$1.27M 0.9% 45
2017
Q1 		$19.9M Sell
620,503
-505,250
-45% -$17.2M 1.01% 36
2016
Q4 		$40.8M Buy
1,125,753
+1,070,000
+1,919% +$42.7M 2.09% 15
2016
Q3 		$2.56M Hold
55,753
– – 0.14% 50
2016
Q2 		$2.8M Hold
55,753
– – 0.16% 48
2016
Q1 		$2.98M Hold
55,753
– – 0.18% 53
2015
Q4 		$3.66M Sell
55,753
-347,281
-86% -$21.5M 0.23% 50
2015
Q3 		$22.8M Hold
403,034
– – 1.7% 26
2015
Q2 		$23.8M Sell
403,034
-400,000
-50% -$24.7M 1.81% 23
2015
Q1 		$50M Sell
803,034
-33,000
-4% -$1.92M 4.05% 9
2014
Q4 		$48.1M Sell
836,034
-50,000
-6% -$2.79M 4.22% 10
2014
Q3 		$47.6M Sell
886,034
-62,200
-7% -$3.3M 3.28% 13
2014
Q2 		$49.7M Sell
948,234
-20,000
-2% -$1.02M 3.98% 8
2014
Q1 		$51.2M Sell
968,234
-264,861
-21% -$12.2M 4.19% 5
2013
Q4 		$49.4M Buy
1,233,095
+342,330
+38% +$13.5M 4.34% 4
2013
Q3 		$33.7M Sell
890,765
-401,425
-31% -$15.7M 3.08% 10
2013
Q2 		$50.7M Buy
+1,292,190
New +$50.3M 4.3% 3

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Menora Mivtachim Holdings's TEVA Position: Q1 2026 in Review

Menora Mivtachim Holdings increased its Teva Pharmaceuticals (TEVA) stake by 0.79% in Q1 2026, buying an estimated $9.98M and bringing the position to 39,626,383 shares worth $1.19B. The position accounts for 5.65% of the portfolio, ranked #3.

Menora Mivtachim Holdings first reported a position in TEVA in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.23B in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Menora Mivtachim Holdings held 39,626,383 shares of Teva Pharmaceuticals worth $1.19B as of Q1 2026.
  • Menora Mivtachim Holdings bought 310,200 Teva Pharmaceuticals shares in Q1 2026, an estimated $9.98M.
  • Teva Pharmaceuticals made up 5.65% of Menora Mivtachim Holdings's portfolio in Q1 2026, its #3 holding.
  • Menora Mivtachim Holdings first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
  • Menora Mivtachim Holdings's Teva Pharmaceuticals position peaked at $1.23B in Q4 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Menora Mivtachim Holdings's 13F filing for Q1 2026, filed 14 May 2026.